Bluejay Diagnostics raises $125,000 in private placement to insiders at $2.00/share

Bluejay Diagnostics, Inc.

Issued 62,500 shares of common stock at $2.00 per share to five insiders, including CEO Neil Dey and Chair Donald Chase.
Gross proceeds of $125,000; sale closed on March 17, 2026, under Section 4(a)(2)/Reg D exemption.
No registration rights were granted; shares are restricted securities.
Proceeds likely used for general working capital; no other material terms disclosed.
All purchasers represented as accredited investors.

item 1.01item 3.02item 9.01

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.